Literature DB >> 20410649

Investigation on the interaction of prulifloxacin with human serum albumin: a spectroscopic analysis.

Ya-Bei Huang1, Shi-Jun Wang, Yan-Qin Zi, Zhang Yu, Xiao-Yan Gao, Ying-Cai Tang, Da-Ming Zhang.   

Abstract

The interaction between prulifloxacin (PUFX) and human serum albumin (HSA) was investigated under simulated physiologic conditions with fluorescence spectra. The fluorescence quenching process of HSA may be mainly governed by a static quenching mechanism. The apparent binding constant K(b) between PUFX and HSA at different temperatures were 2.08+/-1.04, 2.74+/-0.50, and 4.98+/-1.61x10(8) l/mol. The thermodynamic parameters, with a negative value of DeltaG(0), revealed that the binding is a spontaneous process. A binding distance R of 1.19 nm between donor and acceptor was obtained from the Fŏrster energy transfer theory.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410649     DOI: 10.1248/cpb.58.582

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Fluoxetine competes with cortisol for binding to human serum albumin.

Authors:  Mostafa Rezaei-Tavirani; Roya Tadayon; Seyyed Alireza Mortazavi; Arvin Medhet; Said Namaki; Shiva Kalantari; Ellaheh Noshinfar
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

2.  Development and Validation of a RP-HPLC Method for Estimation of Prulifloxacin in Tablet Dosage Form.

Authors:  S Singh; U K Singh; R M Singh; G N Singh; S C Mathur; P K Saini; A Yadav; V Gupta; D Duggal
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.